# A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants

> **NCT06454630** · PHASE2 · COMPLETED · sponsor: **Regeneron Pharmaceuticals** · enrollment: 179 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** REGN7508
- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT06454630
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-27
- **Primary completion:** 2024-11-19
- **Final completion:** 2025-01-21
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06454630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06454630, "A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06454630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*